The impact of the heparin-induced thrombocytopenia (HIT) computerized alert on provider behaviors and patient outcomes
- PMID: 21712374
- PMCID: PMC3197994
- DOI: 10.1136/amiajnl-2011-000138
The impact of the heparin-induced thrombocytopenia (HIT) computerized alert on provider behaviors and patient outcomes
Abstract
Objective: The aim of this study was to measure the effect of an electronic heparin-induced thrombocytopenia (HIT) alert on provider ordering behaviors and on patient outcomes.
Materials and methods: A pop-up alert was created for providers when an individual's platelet values had decreased by 50% or to <100,000/mm(3) in the setting of recent heparin exposure. The authors retrospectively compared inpatients admitted between January 24, 2008 and August 24, 2008 to a control group admitted 1 year prior to the HIT alert. The primary outcome was a change in HIT antibody testing. Secondary outcomes included an assessment of incidence of HIT antibody positivity, percentage of patients started on a direct thrombin inhibitor (DTI), length of stay and overall mortality.
Results: There were 1006 and 1081 patients in the control and intervention groups, respectively. There was a 33% relative increase in HIT antibody test orders (p=0.01), and 33% more of these tests were ordered the first day after the criteria were met when a pop-up alert was given (p=0.03). Heparin was discontinued in 25% more patients in the alerted group (p=0.01), and more direct thrombin inhibitors were ordered for them (p=0.03). The number who tested HIT antibody-positive did not differ, however, between the two groups (p=0.99). The length of stay and mortality were similar in both groups.
Conclusions: The HIT alert significantly impacted provider behaviors. However, the alert did not result in more cases of HIT being detected or an improvement in overall mortality. Our findings do not support implementation of a computerized HIT alert.
Conflict of interest statement
Figures
Similar articles
-
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.Pharmacoeconomics. 2007;25(11):949-61. doi: 10.2165/00019053-200725110-00005. Pharmacoeconomics. 2007. PMID: 17960953
-
Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.Crit Care. 2006;10(6):R161. doi: 10.1186/cc5100. Crit Care. 2006. PMID: 17109753 Free PMC article.
-
Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost.Thromb Haemost. 2012 Nov;108(5):992-8. doi: 10.1160/TH12-05-0289. Epub 2012 Sep 5. Thromb Haemost. 2012. PMID: 22955669
-
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007557. doi: 10.1002/14651858.CD007557.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Apr 21;4:CD007557. doi: 10.1002/14651858.CD007557.pub3. PMID: 22972111 Updated. Review.
-
Heparin-Induced thrombocytopenia: minimising the risks in the elderly patient.Drugs Aging. 2000 May;16(5):351-64. doi: 10.2165/00002512-200016050-00005. Drugs Aging. 2000. PMID: 10917073 Review.
Cited by
-
Effect of electronic records on mortality among patients in hospital and primary healthcare settings: a systematic review and meta-analyses.Front Digit Health. 2024 Jun 26;6:1377826. doi: 10.3389/fdgth.2024.1377826. eCollection 2024. Front Digit Health. 2024. PMID: 38988733 Free PMC article.
-
Electronic alerts to improve management of heparin-induced thrombocytopenia.Res Pract Thromb Haemost. 2024 Apr 30;8(4):102423. doi: 10.1016/j.rpth.2024.102423. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38953054 Free PMC article.
-
The Effect of Digitization on the Safe Management of Anticoagulants.Appl Clin Inform. 2022 Aug;13(4):845-856. doi: 10.1055/a-1910-4339. Epub 2022 Jul 27. Appl Clin Inform. 2022. PMID: 35896507 Free PMC article.
-
Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials.J Med Internet Res. 2021 Apr 9;23(4):e16651. doi: 10.2196/16651. J Med Internet Res. 2021. PMID: 33835035 Free PMC article. Clinical Trial.
-
An automated clinical alert system for newly-diagnosed atrial fibrillation.PLoS One. 2015 Apr 7;10(4):e0122153. doi: 10.1371/journal.pone.0122153. eCollection 2015. PLoS One. 2015. PMID: 25849969 Free PMC article.
References
-
- Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:340S–80S - PubMed
-
- Chong BH. Heparin-induced thrombocytopenia. J Thromb Haemost 2003;1:1471–8 - PubMed
-
- Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003;121:535–55 - PubMed
-
- Oliveira GB, Crespo EM, Becker RC, et al. ; Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med 2008;168:94–102 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
